Your prediction
Advicenne Stock
A loss of -1.270% shows a downward development for Advicenne.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Advicenne stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Advicenne in the next few years
Pros
?
S********** s********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Advicenne vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Advicenne | -1.270% | -2.511% | 6.351% | -5.322% | -11.777% | -57.139% | - |
| Boiron S.A. | -1.780% | 7.478% | 12.160% | 17.490% | 15.730% | -31.180% | -16.033% |
| Onxeo S.A. | 2.740% | -11.515% | -33.636% | 107.681% | 76.116% | -2.796% | -80.507% |
| Virbac S.A. | -2.440% | -1.414% | 2.199% | 8.906% | 11.699% | 44.306% | 61.717% |
